Chlordiazepoxide Hydrochloride and Clidinium Bromide
Chlordiazepoxide Hydrochloride and Clindinium Bromide Capsules
Approved
Approval ID
eb0fd4f8-adf8-436d-b0d3-c28f36228311
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 1, 2016
Manufacturers
FDA
Marlex Pharmaceuticals Inc
DUNS: 782540215
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Chlordiazepoxide Hydrochloride and Clidinium Bromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10135-622
Product Classification
G
Generic Name
Chlordiazepoxide Hydrochloride and Clidinium Bromide
Product Specifications
Route of AdministrationORAL
Effective DateJune 28, 2016
FDA Product Classification
INGREDIENTS (9)
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1S
Classification: IACT
CLIDINIUM BROMIDEActive
Quantity: 2.5 mg in 1 1
Code: 91ZQW5JF1Z
Classification: ACTIB
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
CHLORDIAZEPOXIDE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: MFM6K1XWDK
Classification: ACTIB